Uterine artery embolisation for the treatment of fibroids

National Institute for Clinical Excellence
Record ID 32004000850
English
Authors' objectives:

This study aims to assess the current evidence on uterine artery embolisation for the treatment of fibroids.

Authors' recommendations: 1.1 Current evidence on uterine artery embolisation (UAE) suggests that it is safe enough for routine use and that there is symptomatic benefit in the majority of patients in the short term. However, more evidence is required on the degree and duration of the procedures benefits, and of its effects on fertility. 1.2 Clinicians wishing to undertake UAE should take the following actions. - Ensure that patients understand the uncertainty about the degree and duration of the procedures benefits and provide them with clear written information. Use of the Institute's Information for the Public is recommended. - Audit and review clinical outcomes of all patients having UAE. Data should be submitted to the British Society of Interventional Radiology registry (http://www.bsir.org). 1.3 Patient selection should be made with the involvement of a multidisciplinary team, which should include a gynaecologist and an interventional radiologist. 1.4 The Institute may review the procedure upon publication of further evidence.
Authors' methods: Overview
Details
Project Status: Completed
Year Published: 2004
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Embolization, Therapeutic
  • Leiomyoma
  • Uterine Neoplasms
  • Uterus
Contact
Organisation Name: National Institute for Clinical Excellence
Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name: nice@nice.nhs.uk
Contact Email: nice@nice.nhs.uk
Copyright: National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.